Zai Lab treats first patient in China in PANOVA-3 trial of TTFields
Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase 3 clinical trial of tumor treating fields (TTFields) in pancreatic cancer. Tumor Treating Fields are electric fields which disrupt cancer cell division. PANOVA-3 is a global, open-label, randomized late-stage trial for assessing the efficacy of Tumor Treating […]